Automated chromogenic multiplexed immunohistochemistry assay for diagnosis and predictive biomarker testing in non-small cell lung cancer.
OBJECTIVEThe current challenges in the management of non-small lung cancer cells (NSCLC) in the pathology laboratory is to combine immunohistochemistry (IHC) and molecular approaches on biopsy are getting smaller and …
